found that Tregs in patients with non-small cell lung cancer effectively inhibited the anti-tumor ability of autologous NK cells, and treatment with anti-TGF-β antibody restored the damaged cytotoxic activity of NK cells in tumor tissue (46). Here, TGFB1 is linked to neoplasm.